Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05559866 · ClinicalTrials.gov registry record · NA

Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Trial

A NA study of Obesity, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT05559866: Completed NA study of Obesity, sponsored by Mayo Clinic.

NCT05559866 is a NA study of Obesity that has completed, run by Mayo Clinic. The registered enrollment target is 45 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05559866, a NA study of Obesity, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

This study is being done to evaluate the safety and effectiveness of combined Hybrid Argon Plasma Coagulation (HAPC) and Endoscopic Sleeve Gastroplasty (ESG) for weight loss and improvement in obesity-related co-morbidities compared to ESG alone in participants with a BMI ≥ 30 and ≤40 kg/m² who have failed to achieve and maintain weight loss with a non-surgical program.

Conditions Studied

Interventions

  • DEVICE Apollo ESG
  • DEVICE Apollo ESG with ERBE HAPC

Study Locations (1)

Minnesota

  • Mayo Clinic Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2022-11-18
Est. Completion 2025-01-17
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05559866

The ClinicalTrials.gov registry entry for NCT05559866 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Apollo ESG is the first listed.

NCT05559866 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05559866 about?

NCT05559866 is a clinical study titled "Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Trial". This study is being done to evaluate the safety and effectiveness of combined Hybrid Argon Plasma Coagulation (HAPC) and Endoscopic Sleeve Gastroplasty (ESG) for weight loss and improvement in obesity-related co-morbidities compared to ESG alone in participants with a BMI ≥ 30 and ≤40 kg/m² who have...

What is the current status of trial NCT05559866?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2022-11-18. Estimated completion is 2025-01-17.

What conditions does trial NCT05559866 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT05559866?

The interventions under investigation include: Apollo ESG (DEVICE), Apollo ESG with ERBE HAPC (DEVICE).

Who is sponsoring clinical trial NCT05559866?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05559866 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.